Table S4 from Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium
Year: 2025
Type: other
Abstract: Supplemental Table 4. CRS features
Authors: Beatrice M. Razzo, Shonali Midha, Andrew J. Portuguese, Ariel F. Grajales-Cruz, Andre De Menezes Silva Corraes, Patrick Costello, Yuxin Liu, Adam S. Sperling, Omar Nadeem, Danai Dima, Rahul Banerjee, Andrew J. Cowan, Aimaz Afrough, Larry D. Anderson, Alex Lieberman-Cribbin, Gurbakhash Kaur, Anmol Goyal, Shebli Atrash, Christopher J. Ferreri, Peter M. Voorhees, Oren Pasvolsky, Hans C. Lee, Krina K. Patel, Kelley L. Julian, Peter A. Forsberg, Megan M. Herr, Saurabh Chhabra, Ricardo D. Parrondo, Yi Lin, Anna Chen, Sandra P. Susanibar-Adaniya, Jack Khouri, Shahzad Raza, Faiz Anwer, Mariola Vazquez-Martinez, Omar Castaneda Puglianini, Douglas W. Sborov, James A. Davis, Adriana Rossi, Leyla Shune, Jenny Bhurtel, Wei-Ting Hwang, Doris K. Hansen, Surbhi Sidana, Alfred L. Garfall, Shambavi Richard
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4416114613